Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: Subgroup analysis from a randomized phase 3 study

1. Scagliotti, G.V.
2. Hirsh, V.
3. Siena, S.
4. Henry, D.H.
5. Woll, P.J.
6. Manegold, C.
7. Solal-Celigny, P.
8. Rodriguez, G.
9. Krzakowski, M.
10. Mehta, N.D.
11. Lipton, L.
12. García-Sáenz, J.A.
13. Pereira, J.R.
14. Prabhash, K.
15. Ciuleanu, T.-E.
16. Kanarev, V.
17. Wang, H.
18. Balakumaran, A.
19. Jacobs, I.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1097/JTO.0B013E31826AEC2B GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus